Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation

被引:7
作者
Neelakantan I.V. [1 ]
Di Palma S. [1 ]
Smith C.E.T. [2 ]
McCoombe A. [3 ]
机构
[1] Department of Histopathology, Royal Surrey County Hospital, Egerton Road, Guildford
[2] Department of Histopathology, Frimley Park Hospital, Camberley, Surrey
[3] Department of ENT, Frimley Park Hospital, Camberley, Surrey
关键词
Microsatellite instability; Muir Torre and Lynch syndrome; Parotid gland; Sebaceous carcinoma;
D O I
10.1007/s12105-015-0670-9
中图分类号
学科分类号
摘要
Sebaceous carcinoma of parotid gland are extremely rare with only 29 cases reported so far. The development of parotid sebaceous carcinoma in association with mutation in the mismatch repair gene that causes Muir Torre Syndrome (MTS), a subset of Lynch Syndrome, is still unclear. This study describes such a case and reviews the literature to see if an association between parotid sebaceous carcinoma and multiple visceral malignancies seen in Lynch Syndrome has ever been described. MTS represents a small subset of the Hereditary Non Polyposis Colorectal Carcinoma family, thought to be a subtype of Lynch Syndrome, where patients are prone to develop multiple visceral cancers involving gastrointestinal and genitourinary tract along with sebaceous and non-sebaceous tumours of the skin. MTS is a rare hereditary, autosomal dominant cancer syndrome caused by Microsatellite Instability and defect in DNA mismatch repair protein. The germline mutation involves mostly hMSH2 and hMLH1 genes. In MTS the skin of the head and neck area with the periocular region in particular, is affected but sebaceous carcinomas of the parotid associated with visceral malignancies has not yet been reported in literature. Here we report an index case of sebaceous carcinoma of parotid gland in a patient with MTS. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:354 / 361
页数:7
相关论文
共 49 条
[1]  
Muir E.G., Bell A.J., Barlow K.A., Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthoma of the face, Br J Surg, 54, 3, pp. 191-195, (1967)
[2]  
Torre D., Multiple sebaceous adenomas, Arch Dermatol, 98, 5, pp. 549-551, (1968)
[3]  
Bhaijee F., Brown A.S., Muir Torre syndrome, Arch Pathol Lab Med, 138, pp. 1685-1689, (2014)
[4]  
Navi D., wadhera A., Fung M.A., Fazel N., Muir Torre syndrome, Dermatol Online J, 12, 5, (2006)
[5]  
Hare H.H., Mahendraker N., Sarwate S., Tangella K., Muir Torre syndrome: rare but important disorder, Cutis, 82, 4, pp. 252-256, (2008)
[6]  
Pettey A.A., Walsh J.S., Muir-Torre syndrome: a case report and review of the literature, Cutis, 75, 3, pp. 149-155, (2005)
[7]  
Heather J.H., Melissa V., Jean M.H., Muir Torre syndrome: a case report, J Clin Aesthet Dermatol, 2, (2009)
[8]  
Thibodeau S.N., French A.J., Roche P.C., Et al., Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes, Cancer Res, 56, pp. 4836-4840, (1996)
[9]  
Entius M.M., Keller J.J., Drillenburg P., Kuypers K.C., Giardiello F.M., Offerhaus G.J., Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome, Clin Cancer Res, 6, pp. 1784-1789, (2000)
[10]  
Kruse R., Rutten A., Schweiger N., Et al., Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias, J Invest Dermatol, 120, 5, pp. 858-864, (2003)